-+ 0.00%
-+ 0.00%
-+ 0.00%

Ladenburg Thalmann Downgrades Traws Pharma to Neutral

Benzinga·06/15/2026 16:11:54
Listen to the news
Ladenburg Thalmann analyst Kevin DeGeeter downgrades Traws Pharma (NASDAQ:TRAW) from Buy to Neutral.